Drug development company promoting longevity and finding treatments for age-related diseases
Founded in 2017 and headquartered in Boston, MA, Life Biosciences is pursuing therapies targeting three molecular pathways that regulate the biology of aging: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Our platform approach enables us to develop pharmaceutical treatments with the potential to prevent, treat, and/or reverse multiple aging-related diseases, each with critical unmet needs.
Aging is the biggest risk factor for almost every chronic disease. Ground-breaking research over the past decade has shown that aging is a modifiable risk factor that can be targeted therapeutically. Developing medicines that modify aging biology to prevent, delay, and/or reverse diseases of aging has the potential to transform the practice of medicine.
Visit website: https://lifebiosciences.com/
People at Life Biosciences
Dr. Mehmood Khan is a CEO of Life Biosciences
Tristan Edwards is a Co-Founder & Chief Investment Officer at Life Biosciences
Life Biosciences News
Investing in the Longevity industry
Longevity Technology - 18-Sep-2019
Edwards believes 20–30 years will be added to the average lifespan with none of the ageing diseasesRead more...
Today's 50 year-olds may live another 100 years
Forbes - 26-Aug-2019
Good summary of some major investments in life extension companiesRead more...